AI Article Synopsis
- * The study analyzed how CXCL10 influences CMEC migration using techniques like wound healing assays, Western blotting, and assessing cell proliferation and viability.
- * Results showed that while CXCL10 enhances CMEC migration through the activation of p38 and FAK signaling pathways, it does not affect cell proliferation or viability, highlighting a specific pathway of CMEC motility rather than growth.
Article Abstract
CXCL10 is a chemokine with potent chemotactic activity for immune and non-immune cells expressing its receptor CXCR3. Previous studies have demonstrated that CXCL10 is involved in myocardial infarction. However, the role of CXCL10 in cardiac microvascular endothelial cell (CMEC) regulation and related mechanisms remains unclear. In this study, we investigated the effects of CXCL10 on the CMEC migration and explored its potential molecular mechanism by wound healing, cell proliferation and viability analysis. Furthermore, migration-related signaling pathways, including FAK, Erk, p38 and Smad, were examined by Western blotting. We found that CXCL10 significantly promotes CMEC migration under normal conditions and during hypoxia/ischemia. However, no significant differences in CMEC proliferation and viability were observed with or without CXCL10 treatment. CXCL10-mediated CMEC migration was greatly blocked by treatment with an anti-CXCR3 antibody. Although CXCL10 treatment promoted phosphorylation and activation of the FAK, Erk, and p38 pathways during hypoxia/ischemia, CXCL10-mediated CMEC migration was significantly blocked by p38 and FAK inhibitors, but not by an Erk inhibitor. Furthermore, CXCL10-mediated FAK activation was suppressed by the p38 inhibitor. These findings indicated that the CXCL10/CXCR3 pathway promotes the migration of CMECs under normal conditions and during hypoxia/ischemia in a proliferation-independent manner, at least in part, through regulation of the p38/FAK pathways.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.yexmp.2016.01.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Engineered Biomimetic Nanoparticles-Mediated Targeting Delivery of Allicin Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Ferroptosis.
Int J Nanomedicine
November 2024
Department of Pharmaceutics, Harbin Medical University, Heilongjiang, 163319, People's Republic of China.
Background: Cardiac microvascular damage is substantially related with the onset of myocardial ischaemia-reperfusion (IR) injury. Reportedly, allicin (AL) effectively protects the cardiac microvascular system from IR injury. However, the unsatisfactory therapeutic efficacy of current drugs and insufficient drug delivery to the damaged heart are major concerns.
View Article and Find Full Text PDFShuangshen ningxin formula attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial function.
J Ethnopharmacol
April 2024
Institute of Basic Medical Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, National Clinical Research Center for Cardiovascular Diseases of Traditional Chinese Medicine, Beijing 100091, PR China. Electronic address:
Article Synopsis
- - SSNX is a traditional Chinese medicine used to treat myocardial ischemia-reperfusion injury (MIRI), which has shown promise in reducing cardiovascular events, though its specific mechanisms in protecting microvascular injury are not fully understood.
- - The study aims to explore how SSNX protects the microvasculature in rats and whether this protection is linked to the NR4A1/Mff/Drp1 pathway during I/R injury.
- - Various experimental methods, including histological staining, Western blotting, and cell culture models, were employed to assess cardiac function, evaluate microvascular health, and investigate the underlying molecular mechanisms involving mitochondrial function.
ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3.
Shock
October 2023
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Guizhou, China.
Cardiac macrophages with different polarization phenotypes regulate ventricular remodeling and neovascularization after myocardial infarction (MI). Annexin A2 (ANXA2) promotes macrophage polarization to the repair phenotype and regulates neovascularization. However, whether ANXA2 plays any role in post-MI remodeling and its underlying mechanism remains obscure.
View Article and Find Full Text PDFParacrine effects of mir-210-3p on angiogenesis in hypoxia-treated c-kit-positive cardiac cells.
Ann Med
July 2023
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Treatment with c-kit-positive cardiac cells (CPCs) has been shown to improve the prognosis of ischemic heart disease. MicroRNAs (miRNAs) confer protection by enhancing the cardiac repair process, but their specific functional mechanisms remain unclear. This study aimed to screen for differentially expressed miRNAs in CPCs under hypoxia and explore their effects on the function of CPCs.
View Article and Find Full Text PDFExosomal MiR-29a in Cardiomyocytes Induced by Angiotensin II Regulates Cardiac Microvascular Endothelial Cell Proliferation, Migration and Angiogenesis by Targeting VEGFA.
Curr Gene Ther
June 2022
Department of Cardiology, The Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
Article Synopsis
- Exosomes from cardiomyocytes (CMs) may influence angiogenesis by delivering microRNA (miR) specifically miR-29a, which has a role in regulating both angiogenesis and myocardial hypertrophy.
- The study utilized Angiotensin II (Ang II) to induce hypertrophy in CMs and examined the effects of exosomes on cardiac microvascular endothelial cells (CMECs) in various assays, highlighting the role of miR-29a.
- Findings indicated that Ang II-induced CMs release exosomal miR-29a, which inhibits the proliferation and angiogenic functions of CMECs by targeting and suppressing the expression of vascular endothelial growth factor A (VEGFA).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!